KATHERINE VAN BEURDEN: Open Payments
NPI 1508454364 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,895 in 67 payments from 18 companies in 2025. Trend: 2023 $1,527 · 2024 $1,136 · 2025 $1,895
Food & beverage: $1,885Education: $10
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $493 |
| ABBVIE INC. | 12 | $333 |
| E.R. Squibb & Sons, L.L.C. | 6 | $230 |
| Novartis Pharmaceuticals Corporation | 5 | $126 |
| UCB, Inc. | 4 | $122 |
| Organon LLC | 7 | $96 |
| PFIZER INC. | 4 | $83 |
| Janssen Biotech, Inc. | 4 | $82 |
| Incyte Corporation | 3 | $80 |
| Arcutis Biotherapeutics, Inc. | 3 | $48 |
Products named: EBGLYSS, Sotyktu, TALTZ, RINVOQ, Bimzelx, SKYRIZI, CIBINQO, TREMFYA.
Industry payments across CA — which companies pay providers there.
